Atiya Imran Dr
GLP-1 compounding is appropriate for adults with obesity (BMI 30) or overweight (BMI 25) with weight-related comorbidities, under active provider supervision
Safety Profile in Research Contexts Gastrointestinal events (nausea, vomiting, diarrhea, constipation) remain the most common adverse effects, typically mild to moderate, dose-dependent, and often mitigated by gradual dose escalation starting at lower levels (e.g., 2 mg)
It helps the body reset, particularly during hormonal transitions like perimenopause and menopause , and provides a safe, structured way to support long-term wellbeing
A pinch of salt in water or a sugar-free electrolyte mix usually clears it up fast
It helps to prevent accumulation of fat in the liver